Physician profile
Khalid M Moussa
NPI 1922116631
$1,662.14
in general payments reported to CMS, 2019-2025
17 companies · $91.40 in 2025
The $91.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $538 · 2021: $323 · 2022: $193 · 2023: $122 · 2024: $129 · 2025: $91.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $753.30 | 2019-2022 | |
| Gilead Sciences, INC. | $174.86 | 2019-2023 | Epclusa |
| Phathom Pharmaceuticals, INC. | $145.83 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.92 | 2019-2025 | Relistor |
| Ironwood Pharmaceuticals, INC | $79.86 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.63 | 2020-2021 | |
| Boston Scientific Corporation | $63.76 | 2022 | |
| Conmed Corporation | $59.15 | 2025 | Conmed Generators |
| Daiichi Sankyo INC. | $54.85 | 2019-2020 | |
| Allergan, INC. | $44.45 | 2019 | |
| Nestle Healthcare Nutrition INC. | $39.32 | 2021 | |
| Evoke Pharma, INC. | $20.23 | 2021 | |
| Janssen Biotech, INC. | $19.39 | 2019 | |
| Alfasigma USA, INC. | $16.12 | 2020 | |
| Glaxosmithkline, LLC. | $14.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $13.61 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Moussa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.